ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES

SAVE THE BOTTOMS!!!: ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES

The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.

Study Overview

• Status: Recruiting
• Conditions: Anal Cancer
• Intervention / Treatment: Other: Observational/Survery

• Study Type: Observational
• Enrollment (Estimated): 5000

Contacts and Locations

• Study Contact: Name: Kathryn Vera; Phone Number: 612-625-5018; Email: giero002@umn.edu

Study Locations

• United States
  • Minnesota
    • Minneapolis, Minnesota, United States, 55455
      • Recruiting
      • University of Minnesota
      • Contact: Elliot Arsoniadis, M.D., Ph.D; Phone Number: 612-625-7992; Email: arson001@umn.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

MSM population, which may include individuals who may identify as having a sexual orientation of gay, bisexual, or gender-queer. They may identify as any gender, including trans-gender or non-binary (but limited to those born with sex assigned at birth as male).

Description

Inclusion Criteria:

• ≥18 years of age
• Current resident of the U.S.
• Engage in anoreceptive intercourse with male partners
• Fluent in English or Spanish

Exclusion Criteria:

• Under the age of 18 years old
• Not living in the United States
• Not born with sex assigned at birth as male
• Does not engage in sex with male partners

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Other

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Men who have sex with men (MSM)	Other: Observational/Survery; MSM participants will complete a one-time survey, delivered in an e-format. Survey will be accessible via Meta-based social media platforms (Facebook, Instagram).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
MSM awareness of anal cancer risk	Survey with question items on participants' awareness of anal cancer risk	2 months
MSM awareness of strategies to decrease anal cancer risk	Survey with question items of strategies to decrease anal cancer risk	2 months

Collaborators and Investigators

• Sponsor: University of Minnesota
• Investigators: Principal Investigator: Elliot Arsoniadis, M.D., Ph.D, University of Minnesota

Study record dates

Study Major Dates

• Study Start (Actual): June 8, 2023
• Primary Completion (Estimated): December 31, 2024
• Study Completion (Estimated): December 31, 2024

Study Registration Dates

• First Submitted: November 16, 2022
• First Submitted That Met QC Criteria: November 16, 2022
• First Posted (Actual): November 28, 2022

Study Record Updates

• Last Update Posted (Estimated): April 15, 2024
• Last Update Submitted That Met QC Criteria: April 12, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Gastrointestinal Neoplasms; Digestive System Neoplasms; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colorectal Neoplasms; Rectal Neoplasms; Anus Diseases; Anus Neoplasms
• Other Study ID Numbers: HRP-580

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No